Home

Muschel vorteilhaft mild cowboy rägn kappa verachten Schurke Orientierung

Potent neutralizing nanobodies resist convergent circulating variants of  SARS-CoV-2 by targeting diverse and conserved epitopes | Nature  Communications
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes | Nature Communications

Guideline Therapeutics and COVID-19: living guideline
Guideline Therapeutics and COVID-19: living guideline

An Analysis of Mesenchymal Stem Cell-Derived Extracellular Vesicles for  Preclinical Use | ACS Nano
An Analysis of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Preclinical Use | ACS Nano

Monoclonal antibody therapies against SARS-CoV-2 - The Lancet Infectious  Diseases
Monoclonal antibody therapies against SARS-CoV-2 - The Lancet Infectious Diseases

A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2  variants | Nature Communications
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications

Cancers | Free Full-Text | STAT3: A Novel Molecular Mediator of Resistance  to Chemoradiotherapy | HTML
Cancers | Free Full-Text | STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy | HTML

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion | Nature
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion | Nature

Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic  Separation, Surface Enhanced Raman Spectroscopy Identification, and  Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio  Materials
Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials

新型コロナウイルス感染症に関する 国内外の研究開発動向について
新型コロナウイルス感染症に関する 国内外の研究開発動向について

Engineered extracellular vesicles directed to the spike protein inhibit  SARS-CoV-2: Molecular Therapy - Methods & Clinical Development
Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy - Methods & Clinical Development

Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised  patients treated with bamlanivimab in Germany - The Lancet Regional Health  – Europe
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe

新型コロナウイルス感染症に関する 国内外の研究開発動向について
新型コロナウイルス感染症に関する 国内外の研究開発動向について

SARS-CoV-2 neutralizing human recombinant antibodies selected from  pre-pandemic healthy donors binding at RBD-ACE2 interface | Nature  Communications
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface | Nature Communications

Guideline Therapeutics and COVID-19: living guideline
Guideline Therapeutics and COVID-19: living guideline

ACWI ex JAPAN ex CHINA A 2022 May SAIR Constituent
ACWI ex JAPAN ex CHINA A 2022 May SAIR Constituent

PI16 attenuates response to sorafenib and represents a predictive biomarker  in hepatocellular carcinoma - Wang - 2020 - Cancer Medicine - Wiley Online  Library
PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma - Wang - 2020 - Cancer Medicine - Wiley Online Library

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2  variants of concern | EMBO reports
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports

Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic  Separation, Surface Enhanced Raman Spectroscopy Identification, and  Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio  Materials
Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials

Guideline Therapeutics and COVID-19: living guideline
Guideline Therapeutics and COVID-19: living guideline

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2  variants of concern | EMBO reports
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports

Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic  Separation, Surface Enhanced Raman Spectroscopy Identification, and  Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio  Materials
Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials

新型コロナウイルス感染症に関する 国内外の研究開発動向について
新型コロナウイルス感染症に関する 国内外の研究開発動向について

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2  variants of concern | EMBO reports
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection  in nonhuman primates | Science Translational Medicine
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates | Science Translational Medicine

Molecular aspects of Omicron, vaccine development, and recombinant strain  XE: A review - K - 2022 - Journal of Medical Virology - Wiley Online Library
Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review - K - 2022 - Journal of Medical Virology - Wiley Online Library

Rapid characterization of spike variants via mammalian cell surface display  | bioRxiv
Rapid characterization of spike variants via mammalian cell surface display | bioRxiv

Rapid characterization of spike variants via mammalian cell surface display  - ScienceDirect
Rapid characterization of spike variants via mammalian cell surface display - ScienceDirect

Easy & Reliable – Biomedica´s Cytokine ELISA Kits | Biomedica
Easy & Reliable – Biomedica´s Cytokine ELISA Kits | Biomedica

Frontiers | Developing Recombinant Antibodies by Phage Display Against  Infectious Diseases and Toxins for Diagnostics and Therapy
Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy